Skip to product information
Adaro Test E 250
  • Adaro Test E 250
  • Adaro Test E 250
Adaro Test E 250

Adaro Test E 250

Rs. 100.00
Product Details

Testosterone Enanthate is a long-acting androgen ester used primarily for testosterone replacement therapy (TRT) in males exhibiting clinical symptoms of hypogonadism. Its extended half-life, due to its esterified formulation, allows for a sustained release profile, making it an optimal choice for stable serum testosterone levels.

Indications & Mechanism of Action

AdaroTest E 250 is indicated for:

  1. Primary Hypogonadism (Congenital or Acquired): Testicular dysfunction resulting from cryptorchidism, torsion, orchitis, vanishing testes syndrome, or post-orchidectomy conditions.
  2. Secondary (Hypogonadotropic) Hypogonadism: Impairment due to hypothalamic or pituitary dysfunction, including Kallmann syndrome, idiopathic gonadotropin deficiency, or secondary suppression due to tumors, trauma, or radiation.

Pharmacodynamics:

  • Binds to intracellular androgen receptors, modulating gene transcription.
  • Stimulates protein synthesis, erythropoiesis, bone mineral density, and anabolic processes.
  • Regulates secondary sexual characteristics in males, including muscle mass, fat distribution, libido, and spermatogenesis.
Clinical& Safety

Contraindications:
• Known hypersensitivity to testosterone or any excipients.
• Presence of prostate carcinoma or suspected androgen-sensitive malignancies.
• Male breast carcinoma.
• Severe cardiovascular, hepatic, or renal impairment.
• Pregnant or breastfeeding women due to teratogenic effects (Category X).
Potential Drug Interactions:
• May potentiate the effects of oral anticoagulants (e.g., warfarin), necessitating INR monitoring.
• Alters insulin sensitivity, potentially modifying glucose control in diabetic patients.
• Interacts with corticosteroids and may exacerbate fluid retention.
Adverse Reactions:
• Endocrine effects: Suppression of endogenous testosterone, testicular atrophy, gynecomastia.
• Cardiovascular risks: Elevated hematocrit, risk of hypertension, and increased thrombosis susceptibility.
• Hepatic effects: Rare occurrences of hepatocellular adenomas and peliosis hepatis with prolonged high-dose use.
Dosage & Administration:
• Administer intramuscularly (IM) in the gluteal muscle.
• Standard dosage: 50-400 mg every 2-4 weeks, titrated based on clinical response and serum testosterone levels.
• Not for intravenous use.
Warnings & Precautions

1. Polycythemia Risk: Regular monitoring of hematocrit and hemoglobin is essential to prevent thromboembolic complications.
2. Benign Prostatic Hyperplasia (BPH): Elderly patients require regular PSA and DRE screenings.
3. Lipid Profile Changes: Can reduce HDL cholesterol levels, necessitating periodic lipid panel assessments.
4. Androgenic Effects in Women & Children: Risk of virilization (deep voice, hirsutism, menstrual irregularities).
5. Neuropsychiatric Considerations: Mood swings, aggression, or depression may manifest with excessive androgen exposure.
Storage & Handling

• Store at controlled room temperature (15–30°C).
• Protect from direct sunlight & moisture.
• Inspect vials for precipitation or discoloration before administration.
Ethical& Regulatory

• This product should not be used for performance enhancement in competitive sports.
• Only available via prescription from licensed healthcare professionals.
• Compliance with WADA (World Anti-Doping Agency) & FDA regulations is maintained.
Environmental Impact & Disposal Guidelines
• Do not dispose in household waste or flush into water systems.
• Follow biohazard disposal protocols for ampoules and used needles.

Related items